Curcumin in cancer management: Recent results of analogue design and clinical studies and desirable future research

Molecular Nutrition and Food Research

Volumn 52, Issue 9, 2008, Pages 1005-1009

  Steward, William P ^a   Gescher, Andreas J ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Chemoprevention; Clinical trial; Curcumin

Indexed keywords

ANTINEOPLASTIC AGENT; CURCUMIN; DRUG DERIVATIVE;

CHEMICAL STRUCTURE; CLINICAL TRIAL; CROHN DISEASE; DRUG DESIGN; HUMAN; NEOPLASM; PILOT STUDY; PRECANCER; REFERENCE VALUE; REVIEW; STRUCTURE ACTIVITY RELATION;

ANTINEOPLASTIC AGENTS; CLINICAL TRIALS AS TOPIC; CROHN DISEASE; CURCUMIN; DRUG DESIGN; HUMANS; MODELS, MOLECULAR; NEOPLASMS; PILOT PROJECTS; PRECANCEROUS CONDITIONS; REFERENCE VALUES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 54949136123     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.200700148     Document Type: Review

References (27)

1. Surh, Y. J., Cancer chemoprevention with dietary phytochemicals, Nat. Rev. Cancer 2003, 3, 768-780.
2. Gafner, S., Lee, S. K., Cuendet, M., Barthelemy, M., et al., Biologic evaluation of curcumin and structural derivatives in cancer chemoprevention model systems, Phytochemistry 2004, 65, 2849-2859.
3. Adams, B. K., Ferstl, E. M., Davis, M. C., Herold, M., et al., Synthesis and biological evaluation of novel curcumin analogs as anti-cancer and anti-angiogenesis agents, Bioorg. Med. Chem. 2004, 12, 3871-3883.
4. Weber, W. M., Hunsaker, L. A., Abcouwer, S. F., Deck, L. M., Vander Jagt, D. L., Anti-oxidant activities of curcumin and related enones, Bioorg. Med. Chem. 2005, 13, 3811-3820.
5. Weber, W. M., Hunsaker, L. A., Roybal, C. N., Bobrovnikova-Marion, E. V. et al., Activation of NF kappa B is inhibited by curcumin and related enones, Bioorg. Med. Chem. 2006, 14, 2450-2461.
6. Zambre, A. P., Kulkarni, V. M., Padhye, S., Sandur, S. K., Aggarwal, B. B., Novel curcumin analogs and proliferation targeting TNF-induced NF-kappa B activation in human leukemic KBM-5 cells, Bioorg. Med. Chem. 2006, 14, 7196-7204.
7. Handler, N., Jaeger, W., Puschacher, H., Leisser, K., Erker, T., Synthesis of novel curcumin analogues and their evaluation as selective cyclooxygenase-1 (COX-1) inhibitors, Chem. Pharm. Bull. 2007, 55, 67-71.
8. Jankun, J., Aleem, A. M., Malgorzewicz, S., Szkudlarek, M. et al., Synthetic curcuminoids modulate the arachidonic acid metabolism of human platelet 12-lipoxygenase and reduce sprout formation of human endothelial cells, Mol. Cancer Ther. 2006, 5, 1371-1382.
9. Jha, A., Zhao, J., Cameron, T. S., De Clercq, E., et al., Design, synthesis and biological evaluation of novel curcumin analogues as anti-neoplastic agents, Lett. Drug Design Discov. 2006, 3, 304-310.
10. Ohori, H., Yamakoshi, H., Tomizawa, M., Shibuya, M., et al., Synthesis and biological analysis of new curcumin analogues bearing an enhanced potential for the medicinal treatment of cancer. Mol. Cancer Ther. 2006, 5, 2563-2571.
11. Tamvakopoulos, C., Dimas, K., Sofianos, Z. D., Hatziantoniou, S., et al., Metabolism and anticancer activity of the curcumin analogue, dimethoxycurcumin. Clin. Cancer Res. 2007, 13, 1269-1277.
12. Robinson, T. P., Ehlers, T., Hubbard, R. B., Bai, X. H., et al., Design, synthesis, and biological evaluation of angiogenesis inhibitors: Aromatic enone and dienone analogues of curcumin. Bioorg. Med. Chem. Lett. 2003, 13, 115-117.
13. Adams, B. K., Cai, J. Y., Armstrong, J., Herold, M., et al., EF24, a novel synthetic curcumin analog, induces apoptosis in cancer cells via a redox-dependent mechanism. Anticancer Drugs 2005, 16, 263-275.
14. Cheng, A. L., Hsu, C. H., Lin, J. K., Hsu, M. M., et al., Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions, Anticancer Res. 2001, 21, 2895-2900.
15. Lao, C. D., Ruffin, M. T., Normolle, D., Heath, D. D., et al., Dose escalation study of a curcuminoid formulation, BMC Complement. Alternat. Med. 2006, 6, 10.
16. Holt, P. R., Katz, S., Kirshoff, R., Curcumin therapy in inflammatory bowel disease: A pilot study, Digest Dis. Sci. 2005, 50, 2191-2193.
17. Hanai, H., Iida, T., Takeuchi, K., Watanabe, F., et al., Curcumin maintenance therapy for ulcerative colitis: Randomized, multicenter, double-blind, placebo-controlled trial, Clin. Gastroenterol. Hepatol. 2006, 4, 1502-1506.
18. Garcea, G., Jones, D. J. L., Berry, D. P., Dennison, A. R., et al., Consumption of the putative chemopreventive agent curcumin by cancer patients generates pharmacodynamically active levels in the colorectum, Cancer Epidemiol. Biomarkers Prev. 2005, 14, 120-125.
19. Garcea, G., Jones, D. J. L., Dennison, A., Farmer, P., et al., Detection of curcumin and its metabolites in hepatic tissue and portal blood of patients following oral administration, Br. J. Cancer 2004, 90, 1011-1015.
20. Sharma, R., Euden, S. A., Platton, S. L., Cooke, D. N., et al., Phase I clinical trial of oral curcumin: Biomarkers of systemic activity and compliance, Clin. Cancer Res. 2004, 10, 6847-6854.
21. Rasyid, A., Lelo, A., The effect of curcumin and placebo on human gall bladder function: An ultrasound study, Aliment. Pharmacol. Ther. 1999, 13, 245-249.
22. Shoba, G., Joy, D., Joseph, T., Majeed, M., et al., Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers, Planta Medica 1998, 64, 353-356.
23. Tsvetkov, P., Asher, G., Reiss, V., Shaul, Y., et al., Inhibition of NAD(P)H: quinone oxidoreductase 1 activity and induction of p53 degradation by the natural phenolic compound curcumin, Proc. Natl. Acad. Sci. USA 2005, 102, 5535-5540.
24. Moos, P. J., Edes, K., Mullally, J. E., Fitzpatrick, F. A., Curcumin impairs tumour suppressor p53 function in colon cancer cells, Carcinogenesis 2004, 25, 1611-1617.
25. Howells, L. M., Mitra, A., Manson, M. M., Comparison of oxaliplatin- and curcumin-mediated antiproliferative effects in colorectal cell lines, Int. J. Cancer 2007, 21, 175-183.
26. Li, L., Ahmend, B., Mehta, K., Kurzrock, R., Liposomal curcumin with and without oxaliplatin: effects on cell growth, apoptosis and angiogenesis in colorectal cancer, Mol. Cancer Ther. 2007, 6, 1276-1282.
27. Aggarwal, B. B., Shishodia, S., Takada, Y., Banerjee, S., et al., Curcumin suppresses the paclitaxel-induced nuclear factor-kappa B pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice, Clin. Cancer Res. 2005, 11, 7490-7498.